OptiBiotix Health Plc EBIT

The latest EBIT for OPTBF is $-3.7M as of June 2026. That compares with $-680K in the prior-year period — down 436.8% year over year. That is below the Healthcare sector average of $130B. Investors often review this figure alongside OptiBiotix Health Plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, OPTBF's EBIT moved from $-680K to $-3.7M — a 436.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in OptiBiotix Health Plc's operating scale or balance-sheet position.

Against Healthcare companies, OPTBF currently prints $-3.7M for EBIT, while the sector average sits near $130B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at OptiBiotix Health Plc's growth, margins, and balance sheet.

A EBIT figure of $-3.7M for OPTBF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $130B. Explore the charts below for those layers of context.

After noting OPTBF's EBIT ($-3.7M), review year-over-year change from $-680K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.